Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/24853
Title: May Measurement Month 2018: an analysis of blood pressure screening results from Australia.
Austin Authors: Carnagarin, Revathy;Fonseca, Ricardo;Brockman, Derrin;Critchley, Sue;Tan, Isabella;Trengove, Naomi;Tan, Kearney;Lambert, Gavin W;Cowley, Diane;Burrell, Louise M ;Poulter, Neil R;Beaney, Thomas;Ster, Anca Chis;Xia, Xin;Schlaich, Markus P
Affiliation: Neurovascular Hypertension & Kidney Disease Laboratory, Alfred & Baker Hypertension Network, Baker Heart and Diabetes Institute, Melbourne, Australia
Imperial Clinical Trials Unit, Imperial College London, UK
Medicine (University of Melbourne)
Princess Alexandra Hospital (Queensland Health), Brisbane, Australia
Swinburne University of Technology, Melbourne, Australia
Notre Dame University, Perth, Australia
Macquarie University, Sydney, Australia
Department of Nephrology, Royal Perth Hospital, Perth, Australia
Department of Cardiology, Royal Perth Hospital, Perth, Australia
Department of Primary Care and Public Health, Imperial College London..
Dobney Hypertension Centre, School of Medicine - Royal Perth Hospital Unit, University of Western Australia, Level 3, MRF Building, Rear 50 Murray St, Perth, WA, 6000, Australia
Curtin University, Perth, Australia
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Issue Date: Aug-2020
Date: 2020
Publication information: European Heart Journal Supplements 2020; 22(Suppl H): H17-H19
Abstract: May Measurement Month (MMM), originally initiated as a temporary solution to address the lack of blood pressure (BP) screening programs worldwide, emerged as an effective annual campaign to increase the awareness of hypertension. MMM18, a cross-sectional survey of volunteers aged ≥18 years was carried out during May 2018 predominantly in capital cities across Australia following the standard MMM protocol. Blood pressure screening along with additional information including anthropometric data and responses to questionnaires on demographic, lifestyle, and environmental factors were collected from 3 352 individuals across Australia. After multiple imputation, 1 026 (30.6%) adult Australians had hypertension. Of the 2 936 individuals not on antihypertensive treatment, 610 (20.8%) were hypertensive, and 237 (57.1%) of the 416 individuals receiving antihypertensive treatment had uncontrolled BP. In line with MMM17 results and other previous surveys, MMM18 revealed that close to one-third of the screened population (30.6%) had hypertension, 57.1% of individuals treated with BP-lowering medication remained uncontrolled indicating suboptimal management of the condition in the majority of patients. Most importantly, only 49.0% of those with hypertension were aware of their elevated BP, highlighting lack of awareness of elevated BP in nearly half of the affected population. Elevated BP was directly associated with alcohol consumption, overweight, and obesity. Our findings demonstrate the need for (i) continued efforts to increase BP awareness in the population, (ii) optimization of BP management strategies, and (iii) tackling some of the major contributors to BP elevation, including alcohol consumption and obesity.
URI: https://ahro.austin.org.au/austinjspui/handle/1/24853
DOI: 10.1093/eurheartj/suaa018
Journal: European Heart Journal Supplements
PubMed URL: 32884459
ISSN: 1520-765X
Type: Journal Article
Subjects: Awareness
Blood pressure
Control
Hypertension
Screening
Treatment
Appears in Collections:Journal articles

Show full item record

Page view(s)

68
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.